Recall Record

Mumbai, India

Macleods Pharmaceuticals Ltd recalls

4 recalls recorded since 2018, most recently on 27 August 2026. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)4
Terminated or completed0
Class I (FDA)0

Ongoing Class III Drugs

Recall started
27 August 2026
Reason
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0867-2026

Ongoing Class III Drugs

Recall started
11 June 2025
Reason
Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
Distribution
U.S. Nationwide.
Initiated
Voluntary: Firm initiated
Recall number
D-0509-2025

Ongoing Class III Drugs

Recall started
29 May 2025
Reason
Presence of a foreign substance: black hair found embedded in tablet.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0470-2025

Ongoing Class II Drugs

Recall started
25 November 2024
Reason
Failed Impurities/Degradation Specifications
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0154-2025

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.